Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative ferric carboxymaltose for iron-deficient colorectal cancer patients
ACTRN12616001219471Phase 4Recruiting
- Sponsor
- Peter MacCallum Cancer Centre
- Start
- Oct 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in iron deficiency anemia (IDA), anaemia and colorectal cancer (CRC) comparing Ferric carboxymaltose with Placebo saline (2 arms). Primary endpoint: Change in VO2peak. Started Oct 2016; status: recruiting.
02
Drugs
ferric carboxymaltose
03
Conditions
iron deficiency anemia (IDA)anaemiacolorectal cancer (CRC)
Beyond the preview
Go deeper on ACTRN12616001219471.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12616001219471.